Tibotec, Aspen will provide AIDS drug to Africa
Tibotec said it selected Aspen because of its extensive African distribution network. Aspen and Tibotec will share the responsibility for ensuring prompt and affordable access to patients in
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.